oldid139880

Actavis: 0.4 million euros to rebrand Sindan

Iceland-based Actavis has estimated that it will cost 0.4 million euros to rebrand Sindan, a drug producer that it acquired last year. The process is unfolding in several stages, from changing the name from Sindan to Actavis, to achieving brand awareness with...